Can we accelerate fracture healing?. A critical analysis of the literature

Injury

Volumn 38, Issue SUPPL. 1, 2007, Pages

  Giannoudis, Peter ^a   Psarakis, Spyridon ^a   Kontakis, George ^b  

^a UNIVERSITY OF LEEDS   (United Kingdom)

^b UNIVERSITY OF CRETE   (Greece)

Author keywords

Acceleration; BMPs; Fracture healing; Growth factors

Indexed keywords

COLLAGEN; DRUG CARRIER; FIBROBLAST GROWTH FACTOR 1; FIBROBLAST GROWTH FACTOR 2; RECOMBINANT BASIC FIBROBLAST GROWTH FACTOR; RECOMBINANT BONE MORPHOGENETIC PROTEIN 2; RECOMBINANT OSTEOGENIC PROTEIN 1; SOMATOMEDIN C; THROMBIN DERIVATIVE; TP 508; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1; TRANSFORMING GROWTH FACTOR BETA2; UNCLASSIFIED DRUG; VASCULOTROPIN;

ARTICLE; BIOMECHANICS; BONE RADIOGRAPHY; BONE REMODELING; BONE TURNOVER; CLINICAL TRIAL; CONTINUOUS INFUSION; DRUG EFFICACY; DRUG FORMULATION; EXPERIMENTAL MODEL; FEMUR FRACTURE; FIBULA FRACTURE; FRACTURE; FRACTURE HEALING; FRACTURE REDUCTION; HUMAN; INTRAMEDULLARY NAILING; MOLECULAR BIOLOGY; MOLECULAR MECHANICS; NONHUMAN; PRIORITY JOURNAL; TIBIA FRACTURE; TREATMENT OUTCOME; ULNA FRACTURE;

ANIMALS; BONE MORPHOGENETIC PROTEINS; BONE REGENERATION; CELL COMMUNICATION; FRACTURE HEALING; FRACTURES, BONE; HUMANS; MODELS, ANIMAL; TIME FACTORS;

EID: 33947311076     PISSN: 00201383     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.injury.2007.02.013     Document Type: Article

References (69)

1. Atti E, Abjornson C, Diegmann M, et al. High resolution X-ray computed tomography as a technique to study osteoinductivity of demineralised bone matrix. Proceedings of the NASS 18th Annual Meeting. Spine. 2003 3:120S.
2. Bauer T.W., and Muschler G.F. Bone graft materials. An overview of the basic science. Clin Orthop 371 (2000) 10-27
3. Bax B.E., Wozney J.M., and Ashhurst D.E. Bone morphogenetic protein-2 increases the rate of callus formation after fracture of the rabbit tibia. Calcif Tissue Int 65 1 (1999) 83-89
4. Bland Y.S., Critchlow M.A., and Ashhurst D.E. Exogenous fibroblast growth factors-1 and -2 do not accelerate fracture healing in the rabbit. Acta Orthop Scand 66 6 (1995) 543-548
5. Blum B., Moseley J., Miller L., et al. Measurement of bone morphogenetic proteins and other growth factors in demineralised bone matrix. Orthopedics 2791 Suppl (2004) s161-s165
6. Boden S.D., Kang J., Sandhu H., et al. Use of recombinant human bone morphogenetic protein-2 to achieve posterolateral lumbar spine fusion in humans: a prospective, randomized clinical pilot trial: 2002 Volvo Award in clinical studies. Spine 27 23 (2002) 2662-2673
7. Boden S.D., Martin Jr. G.I., Morone M.A., et al. Posterolateral lumbar intertransverse process spine arthrodesis with recombinant human bone morphogenetic protein 2/hydroxyapatitetricalcium phosphate after laminectomy in the nonhuman primate. Spine 24 12 (1999) 1179-1185
8. Bostrom M.P. Expression of Bone Morphogenetic Proteins in Fracture Healing. Clin Orthop 355S (1998) 116-123
9. Bouxsein M.L., Turek T.J., Blake C.A., et al. Recombinant human bone morphogenetic protein-2 accelerates healing in a rabbit ulnar osteotomy model. J Bone Joint Surg Am 83-A 8 (2001) 1219-1230
10. Brighton C.T., Shaman P., Heppenstall R.B., Esterhai, et al. Tibial non-union treated with direct current, capacitive coupling, or bone graft. Clin Orthop 321 (1995) 223-234
11. Chen W.J., Jingushi S., Aoyama I., et al. Effects of FGF-2 on metaphyseal fracture repair in rabbit tibiae. J Bone Miner Metab 22 4 (2004) 303-309
12. Claffey K.P., Abrams K., Shih S.C., et al. Fibroblast growth factor 2 activation of stromal cell vascular endothelial growth factor expression and angiogenesis. Lab Invest 81 1 (2001) 61-75
13. Cook S.D., Barrack R.L., Patron L.P., et al. Osteogenic protein-1 in knee arthritis and arthroplasty. Clin Orthop 428 (2004) 140-145
14. Cook S.D., Dalton J.E., Tan E.H., et al. In vivo evaluation of recombinant human steogenic protein (rhOP-1) implants as a bone graft substitute for spinal fusions. Spine 19 15 (1994) 1655-1663
15. Cook S.D., Wolfe M.W., Salkeld S.L., et al. Effect of recombinant human osteogenic protein-1 on healing of segmental defects in non-human primates. J Bone Joint Surg Am 77 5 (1995) 734-750
16. Critchlow M.A., Bland Y.S., and Ashhurst D.E. he effect of exogenous transforming growth factor-beta 2 on healing fractures in the rabbit. Bone 16 5 (1995) 521-527
17. Deckers M.M., van Bezooijen R.L., van der Horst G., et al. Bone morphogenetic proteins stimulate angiogenesis through osteoblast-derived vascular endothelial growth factor A. Endocrinology 143 4 (2002) 1545-1553
18. den Boer F.C., Bramer J.A., Blokhuis T.J., et al. Effect of recombinant human osteogenic protein-1 on the healing of a freshly closed diaphyseal fracture. Bone 31 1 (2002) 158-164
19. Dimitriou R., Dahabreh Z., Katsoulis E., et al. Application of recombinant BMP-7 on persistent upper and lower limb nonunions. Injury 36 Suppl 4 (2005) S51-S59
20. Dimitriou R., Tsiridis E., and Giannoudis P.V. Current concepts of molecular aspects of bone healing. Injury 36 12 (2005) 1392-1404
21. Dong Y., and Canalis E. Insulin-like growth factor (IGF) I and retinoic acid induce the synthesis of IGF-binding protein 5 in rat osteoblastic cells. Endocrinology 136 5 (1995) 2000-2006
22. Einhorn T.A., Majeska R.J., Mohaideen A., et al. A single percutaneous injection of recombinant human bone morphogenetic protein-2 accelerates fracture repair. J Bone Joint Surg Am 85-A 8 (2003) 1425-1435
23. Fakhry A., Ratisoontorn C., Vedhachalam C., et al. Effects of FGF-2/-9 in calvarial bone cell cultures: differentiation stage-dependent mitogenic effect, inverse regulation of BMP-2 and noggin, and enhancement of osteogenic potential. Bone 36 2 (2005) 254-266
24. Friedlaender G.E., Perry C.R., Cole J.D., et al. Osteogenic protein-1 (bone morphogenetic protein-7) in the treatment of tibial nonunions:A prospective, randomized clinical trial comparing rhOP-1 with fresh bone autograft. J Bone Joint Surg Am 83 (2001) 151-158
25. Gazzerro E., Pereira R.C., Jorgetti V., et al. Skeletal overexpression of gremlin impairs bone formation and causes osteopenia. Endocrinology 146 2 (2005) 655-665
26. Giannoudis P.V., and Pountos I. Tissue regeneration. The past, the present and the future. Injury 36 Suppl 4 (2005) S2-S5
27. Giannoudis P.V., and Tzioupis C. Clinical applications of BMP-7: the UK perspective. Injury 36 Suppl 3 (2005) S47-S50
28. Govender S., Csimma C., Genant H.K., et al. BMP-2 Evaluation in Surgery for Tibial Trauma (BESTT) Study Group. Recombinant human bone morphogenetic protein-2 for treatment of open tibial fractures: a prospective, controlled, randomized study of four hundred and fifty patients. J Bone Joint Surg Am 84-A 12 (2002) 2123-2134
29. Han B., Tang B., and Nimni M. A quantitative and sensitive in vitro assay of osteoinductive activity of demineralized bone matrix. J Orthop Res 21 4 (2003) 648-654
30. Harwood P.J., and Giannoudis P.V. Application of bone morphogenetic proteins in orthopaedic practice: their efficacy and side effects. Expert Opin Drug Saf 4 1 (2005) 75-89
31. Healy W.L., Jupiter J.B., Kristiansen T.K., et al. Nonunion of the proximal humerus. J Orthop Trauma 4 (1990) 424-431
32. Johnson E.E., Urist M.R., and Finerman G.A. Resistant nonunions and partial or complete segmental defects of long bones. Treatment with implants of a composite of human bone morphogenetic protein (BMP) and autolyzed, antigen-extracted, allogeneic (AAA) bone. Clin Orthop 277 (1992) 229-237
33. Jones AL, Swiontkowski MF, Polly DW, et al. Use of rhBMP-2 in the treatment of open tibial shaft fractures: Do improved outcomes outweigh the additional expense of rhBMP-2? abstract. OTA 20th Annual Meeting. 2004.
34. Kawaguchi H., Kurokawa T., Hanada K., et al. Stimulation of fracture repair by recombinant human basic fibroblast growth factor in normal and streptozotocin-diabetic rats. Endocrinology 135 2 (1994) 774-781
35. Kawaguchi H., Nakamura K., Tabata Y., et al. Acceleration of fracture healing in nonhuman primates by fibroblast growth factor-2. J Clin Endocrinol Metab 86 2 (2001) 875-880
36. Kay J.F., Vaughan L.M. Proportional osteoinduction of DBM graft materials. IsoTis OrthoBiologics, Inc. Data on file.
37. Li R.H., Bouxsein M.L., Blake C.A., et al. rhBMP-2 injected in a calcium phosphate paste (alpha-BSM) accelerates healing in the rabbit ulnar osteotomy model. J Orthop Res 21 6 (2003) 997-1004
38. Lieberman J.R., Conduah A., and Urist M.R. Treatment of osteonecrosis of the femoral head with core decompression and human bone morphogenetic protein. Clin Orthop 429 (2004) 139-145
39. Lieberman J.R., Daluiski A., and Einhorn T.A. The role of growth factors in the repair of bone. Biology and clinical applications. J Bone Joint Surg Am 84-A 6 (2002) 1032-1044
40. Lind M., Schumacker B., Soballe K., et al. Transforming growth factor-beta enhances fracture healing in rabbit tibiae. Acta Orthop Scand 64 5 (1993) 553-556
41. Mandracchia V.J., Nelson S.C., and Barp E.A. Current concepts of bone healing. Clin Podiatr Med Surg 8 1 (2001) 55-77
42. McKee MD. and the Canadian Orthopaedic Trauma Society. The effect of human recombinant bone morphogenic protein (RHBMP-7) on the healing of open Tibial shaft fractures: results of a multi-center, prospective, randomized clinical trial. Orthopaedic Trauma Association. 2002 Annual Meeting, Toronto, Ontario, Canada, October 12; Paper 45.
43. McKee MD, Schemitsch EH, Waddell JP, et al. The effect of human recombinant bone morphogenic protein (rhBMP-7) on the healing of open tibial shaft fractures: results of a multicenter, prospective, randomized clinical trial. Read at the Annual Meeting of the American Academy of Orthopaedic Surgeons; Feb 5-9 2003; New Orleans, LA.
44. Midy V., and Plouet J. Vasculotropin/vascular endothelial growth factor induces differentiation in cultured osteoblasts. Biochem Biophys Res Commun 199 1 (1994) 380-386
45. Mont M.A., Jones L.C., Elias J.J., et al. Strut-autografting with and without osteogenic protein-1: a preliminary study of a canine femoral head defect model. J Bone Joint Surg Am 83-A 7 (2001) 1013-1022
46. Nakajima F., Ogasawara A., Goto K., et al. Spatial and temporal gene expression in chondrogenesis during fracture healing and the effects of basic fibroblast growth factor. J Orthop Res 19 5 (2001) 935-944
47. Nakamura T., Hara Y., Tagawa M., et al., Tamura M., Yuge T., Fukuda H., Nigi H. Recombinant human basic fibroblast growth factor accelerates fracture healing by enhancing callus remodeling in experimental dog tibial fracture. J Bone Miner Res 13 6 (1998) 942-949
48. Nielsen H.M., Andreassen T.T., Ledet T., et al. Local injection of TGF-beta increases the strength of tibial fractures in the rat. Acta Orthop Scand 65 1 (1994) 37-41
49. Papakostidis C, Grotz MR, Papadokostakis G, et al. Femoral Biologic Plate Fixation. Clin Orthop Relat Res. 2006 May 11;.Epub ahead of print.
50. Park S.H., O'Connor K.M., and McKellop H. Interaction between active motion and exogenous transforming growth factor Beta during tibial fracture repair. J Orthop Trauma 17 1 (2003) 2-10
51. Paterson D.C., Lewis G.N., and Cass C.A. Treatment of delayed union and nonunion with an implanted direct current stimulator. Clin Orthop 148 (1980) 117-128
52. Pountos I., and Giannoudis P.V. Biology of mesenchymal stem cells. Injury 36 Suppl 3 (2005) S8-S12
53. Radomsky M.L., Aufdemorte T.B., Swain L.D., et al. Novel formulation of fibroblast growth factor-2 in a hyaluronan gel accelerates fracture healing in nonhuman primates. J Orthop Res 17 4 (1999) 607-614
54. Sakou T. Bone morphogenetic proteins: from basic studies to clinical approaches. Bone 22 (1998) 591-603
55. Schaden W., Fischer A., and Sailler A. Extracorporeal shock wave therapy of nonunion or delayed osseous union. Clin Orthop 387 (2001) 90-94
56. Schmidmaier G., Wildemann B., Gabelein T., et al. Synergistic effect of IGF-I and TGF-beta1 on fracture healing in rats: single versus combined application of IGF-I and TGF-beta1. Acta Orthop Scand 74 5 (2003) 604-610
57. Seeherman H.J., Bouxsein M., Kim H., et al. Recombinant human bone morphogenetic protein-2 delivered in an injectable calcium phosphate paste accelerates osteotomy-site healing in a nonhuman primate model. J Bone Joint Surg Am 86-A 9 (2004) 1961-1972
58. Shen H.C., Peng H., Usas A., et al. Structural and functional healing of critical-size segmental bone defects by transduced muscle-derived cells expressing BMP4. J Gene Med 6 9 (2004) 984-991
59. Street J., Bao M., deGuzman L., et al., Bunting S., Peale Jr. F.V., Ferrara N., Steinmetz H., Hoeffel J., Cleland J.L., Daugherty A., van Bruggen N., Redmond H.P., Carano R.A., Filvaroff E.H. Vascular endothelial growth factor stimulates bone repair by promoting angiogenesis and bone turnover. Proc Natl Acad Sci USA 99 15 (2002) 9656-9661
60. Swiontkowski M.F., Aro H.T., Donell S., et al. Recombinant human bone morphogenetic protein-2 in open tibial fractures. A subgroup analysis of data combined from two prospective randomized studies. J Bone Joint Surg Am 88 6 (2006) 1258-1265
61. Termaat M.F., Den Boer F.C., Bakker F.C., et al. Bone morphogenetic proteins. Development and clinical efficacy in the treatment of fractures and bone defects. J Bone Joint Surg Am 87 6 (2005) 1367-1378
62. Vaccaro A.R., Patel T., Fischgrund J., et al. A pilot safety and efficacy study of OP-1 putty (rhBMP-7) as an adjunct to iliac crest autograft in posterolateral lumbar fusions. Eur Spine J 12 5 (2003) 495-500
63. ® (Osteogenic Protein 1) in the treatment of tibial nonunions in the UK and Germany [poster presentation]. 6th EFFORT Congress, 2003.
64. Wan M., and Cao X. BMP signalling in skeletal development. Biochem Biophys Res Commun 328 3 (2005) 651-657
65. Wang H., Li X., Tomin E., et al. Thrombin peptide (TP508) promotes fracture repair by up-regulating inflammatory mediators, early growth factors, and increasing angiogenesis. J Orthop Res 23 3 (2005) 671-679
66. Welch R.D., Jones A.L., and Bucholz R.W. Effect of recombinant human bone morphogenetic protein-2 on fracture healing in a goat tibial fracture model. J Bone Miner Res 13 9 (1998) 1483-1490
67. Wildemann B., Schmidmaier G., Ordel S., et al. Cell proliferation and differentiation during fracture healing are influenced by locally applied IGF-I and TGF-beta1: comparison of two proliferation markers. PCNA and BrdU. J Biomed Mater Res B Appl Biomater 65 1 (2003) 150-156
68. Yoo J, Birkedal J, Changs S, et al. Spinal arthrodesis using a demineralized bone/hyaluronan matrix and bone marrow. Proceedings of the NASS 18th Annual Meeting. Spine J. 2003 3: 143S.
69. Zhang R., An Y., Toth C.A., et al. Osteogenic protein-1 enhances osteointegration of titanium implants coated with periapatite in rabbit femoral defect. J Biomed Mater Res 71B 2 (2004) 408-413